ACM Research designs and manufactures wet processing tools used in wafer fabrication and advanced packaging. Recent filings show solid top-line momentum with first quarter 2026 revenue of 231.3 million dollars, up 34 percent year over year, and management maintained full-year 2026 revenue guidance of 1.08 to 1.175 billion dollars.
However, cash conversion remains volatile due to customer-acceptance timing for first tools: free cash flow for the quarter was negative 52.1 million dollars and our TTM free cash flow estimate is negative 108 million dollars.
The company ended March 31, 2026 with cash, restricted cash and short-term time deposits of about 1.25 billion dollars and net cash of 924 million dollars. Quality is mixed. Technology differentiation in single-wafer cleaning and growing electrochemical plating and furnace lines is real, and founder-CEO David H.
Wang controls approximately 57 percent of total voting power, providing long-term orientation. Yet risk is elevated: 2025 revenue was about 99.6 percent from mainland China and U.S. export-control frameworks remain fluid.
Our base-case quality assessment rewards the product breadth and balance sheet but discounts for geographic concentration, acceptance-based revenue recognition and cyclicality typical of wafer fab equipment suppliers. Valuation on preferred TTM free cash flow is not meaningful today due to negative TTM FCF.
We therefore anchor fair value primarily on TTM EBIT with a conservative multiple reflecting the company’s China exposure and cyclicality, and we cross-check with TTM net income attributable to ACM Research. Relative to a 10-year U.S.
Treasury yield near 4.5 percent, our fair-return hurdle supports a moderate multiple on current earnings power until cash conversion normalizes.
Intangibles: Moderate. ACM Research reports more than 590 patents and differentiation in single-wafer cleaning (SAPS, TEBO) with attractive gross margins in the mid-40s. However, incumbents in wet-process equipment are well-funded and global, limiting durability of pure IP advantages. Switching costs: Moderate to moderately high.
Once qualified, process tools tend to remain in place for the node’s lifecycle, creating friction to swap vendors. ACM’s revenue policy distinguishes first-tool acceptances versus repeat shipments, highlighting the hurdle to initial adoption but persistence thereafter. Network effects: None. Cost advantage: Moderate.
Localized manufacturing and support in China can be cost-efficient relative to foreign peers, but price competition in China caps pricing leverage. Efficient scale: Moderate in niche steps and at certain Chinese fabs, yet the global market remains large with powerful rivals.
Overall, multiple but not dominant moat pillars, discounted for potential erosion if export regimes or domestic competitors shift the landscape.
Gross margin has generally been in the mid-to-high 40 percent range recently, indicating some pricing discipline relative to cost of goods. Still, customers are concentrated and largely based in China; procurement there is price-sensitive and policy-driven.
The company’s unique cleaning approaches can command premium versus local peers for certain steps, but broad-based price increases without volume risk appear limited. Near-term mix shifts toward ECP and other categories can support blended margin, but we do not underwrite latent Verisign- or ASML-like pricing power.
Predictability is the weakest pillar. Revenue recognition for first tools occurs upon customer acceptance, which creates timing volatility in revenue, working capital and free cash flow.
The end market is cyclic and capex-driven, and ACM’s 2025 revenue was roughly 99.6 percent from mainland China, exposing the model to licensing and policy changes beyond management’s control.
While management reaffirmed 2026 revenue guidance and reported robust shipments, we continue to discount for acceptance timing, customer concentration and macro-policy overlays.
Balance sheet strength is a key offset. As of March 31, 2026, cash, restricted cash and short-term time deposits totaled about 1.25 billion dollars and net cash was approximately 924 million dollars.
Borrowings were about 328 million dollars, implying ample liquidity and optionality even as TTM free cash flow is negative from working-capital absorption and capex.
Non-controlling interest is substantial due to the majority-owned ACM Shanghai subsidiary; investors should recognize that a portion of the consolidated cash and earnings belongs to minority holders.
Reinvestment is focused on R&D, broader product categories (ECP, furnace, track, PECVD) and capacity expansion in Lingang and Oregon, which can strengthen competitive position and diversify revenue.
ACM Shanghai sold approximately 4.8 million shares in Q1 2026, raising around 110 million dollars gross, and a proposed H-share listing in Hong Kong aims to expand access to capital. We view these moves as pragmatic but they also increase structure complexity and highlight reliance on Chinese capital markets.
No dividend; buybacks are not a major lever today. Stock-based compensation is meaningful but trending lower year over year in Q1 2026.
Founder-CEO David H. Wang has deep domain expertise and long tenure, and beneficially controls roughly 57 percent of total voting power via dual-class structure, which supports long-term execution and rapid strategic moves. The trade-off is concentrated control and limited external governance pressure.
The senior team combines U.S. and China operating experience, and the company continues to ship and qualify new products across multiple steps, signaling operational capability.

Is ACM Research a good investment at $77?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.